ArticlePharmaceuticals (Basel, Switzerland)2020

Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics.

Anna Maria Piras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.